The introduction of devices for transcatheter aortic valve implantation, mitral repair, and closure of prosthetic paravalvular leaks has led to
a greatly expanded armamentarium of catheter-based approaches to patients with regurgitant as well as stenotic valvular disease. Echocardiography plays an essential role in identifying patients suitable for these interventions and in providing intra-procedural monitoring. Moreover, echocardiography is the primary modality for post-procedure follow-up. The echocardiographic assessment of patients undergoing transcatheter interventions places demands on echocardiographers that differ from those of the routine evaluation of patients with native or prosthetic valvular disease. Consequently, the European Association of Echocardiography in partnership with the American Society of Echocardiography has developed the recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. It is intended that this document will serve as a reference for echocardiographers participating in any or all stages of new transcatheter treatments for patients with valvular heart disease.
Imaging Institute and
Latest posts by Schoenhagen Paul (see all)
- Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis. - February 21, 2017
- Stenotic Flow Reserve Derived from Quantitative Coronary Angiography has Modest but Incremental Value in Predicting Functionally Significant Coronary Stenosis as Evaluated by Fractional Flow Reserve - February 9, 2017
- Gadolinium Retention in the Body and Brain: Is It Time for an International Joint Research Effort? - January 13, 2017